HemoShear: HemoShear Therapeutics Advancing Novel Modulators Against Second Target for Horizon Therapeutics' Gout Discovery Pipeline
Fifth Milestone Achieved by HemoShear with Novel Compounds for Second Target CHARLOTTESVILLE, Va., Sept. 21, 2022 /PRNewswire/ -- HemoShear Therapeutics, Inc., a privately held cli...
Read full article »
HemoShear is a Virginia-based biotechnology company that researches and develops novel therapeutics for the treatment of liver and metabolic disorders.
Read more